Navigation Links
Evidence against use of Beta blockers as first choice in the treatment of primary hypertension

Beta blockers have been used widely in the treatment of hypertension and are still recommended as first-line drugs in hypertension guidelines. Moreover, after myocardial infarction and in patients with heart failure, treatment // with beta blockers prevents re-infarction, hospitalisation for heart failure, and premature death. However, a preliminary analysis has shown that atenolol is not very effective in hypertension.

A recent study, published in the October-November issue of The Lancet, was conducted with the aim to substantially enlarge previous data on atenolol and analyse the effect of different beta blockers on stroke, myocardial infarction, and mortality of all causes .

For the study, the Cochrane Library and PubMed were searched for beta blocker treatment in patients with primary hypertension. Data were then entered into the Cochrane Collaboration Review Manager package and were summarised in meta-analyses. 13 randomised controlled trials were included in a meta-analysis comparing treatment with beta blockers with other antihypertensive drugs. Seven studies were included in a comparison of beta blockers and placebo or no treatment..

Results obtained showed that the relative risk of stroke was 16% higher for beta blockers than for other drugs. There was no difference for myocardial infarction. When the effect of beta blockers was compared with that of placebo or no treatment, the relative risk of stroke was reduced by 19% for all beta blockers, about half that expected from previous hypertension trials. There was no difference for myocardial infarction or mortality.

The authors conclude that in comparison with other antihypertensive drugs, the effect of beta blockers is less than optimum, with a raised risk of stroke.

The authors suggest that beta blockers should not remain first choice in the treatment of primary hypertension and should not be used as reference drugs in future randomised controlled tr
'"/>




Page: 1 2

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Evidence supporting H.pylori eradication
3. Evidences that Better Health Care Facility is Offered By Public Hospitals.
4. First Conclusive Evidence Linking Oral Bacteria To Premature Babies
5. Study Provides Evidence That Obesity Leads To A More Aggressive Ovarian Cancer
6. No Clear Evidence for Ultra-Low Cholesterol Targets?
7. Lack of Evidence on Treatment for Narrowed Kidney Arteries
8. Some Evidence Shows Chinese Herbal Medicine Helps Angina Patients
9. Strong Evidence Suggests Incidence Of Mating Of Ancestors With Neanderthals
10. Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition
11. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...econd largest AIDS capital in the United States. T...ics//. However its been found that primary care pr... are often failing to offer either HIV testing or ...a new UCLA AIDS Institute study. Hence AIDS cases ...
...chronic diseases], more people can live longer.'Ra...vent and treat diseases are bringing// closer the ...tential to live 100 years or longer, said Dr. Pasc...ty of Miami Miller School of Medicine. ''In five ...
...wmakers -- including Sens. Debbie Stabenow (D-Mich... Cubin (R-Wyo.) and Lois Capps (D-Calif.) -- earli...1014) that aims to improve heart disease education...d increase women's access to heart disease screeni...
...t study, the ages at which teenagers and children ...e a significant impact on their delinquent behavio... is a case of first intercourse earlier than their...was published in February edition of the Journal o...
Other Medicine News:Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 2Health News:Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests 3Health News:Genetics Might Engineer Path to Successful Aging 2
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Susan G. Komen for th...n unprecedented $100,million in grants to American...ast track breast cancer research. Grants were also... from the Barbara Ann Karmanos Cancer Institute an... Boerner, Ph.D., assistant,professor, and Guojun W...
(Date:10/14/2008)...t. 10 /- Regado Biosciences, Inc.,an... in the Phase IIa,clinical study of its REG1 Antic...percutaneous coronary intervention (PCI). REG1 is ...d anticoagulant, RB006, and its matched,active re...nd neutralizes,RB006. The Phase IIa study (REVERSA...
(Date:10/13/2008)... million dollar NIH funding advances study S... rates, MINNEAPOLIS, Oct. 13 /- Adva...edcirculatory.com ) announced today that it has re...the National Institutes of,Health (NIH) to continu...on,those who experience cardiac arrest outside a h...
(Date:10/13/2008)...nnounce Interim Results in January 2009 and Final ..., EMERYVILLE, Calif., Oct. 13 /PRNewswire-FirstCa... (Nasdaq: NTII ) today announced that following a...n to discuss the,Viprinex(TM) (ancrod) Phase 3 cli...ny plans to consolidate and analyze data from its ...
Breaking Medicine Technology:Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 2Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 3Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 4Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants 5Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 2Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4Before Every Surgery Take a TIME OUT 28R 29 5745 1Before Every Surgery Take a TIME OUT 28R 29 5745 2Black Athletes Hearts May Differ From Those of Whites 20899 1Black Athletes Hearts May Differ From Those of Whites 20899 2Black Athletes Hearts May Differ From Those of Whites 20899 3Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 1Katzen Eye Group Announces a New Option in Vision Correction Technology for Patients 20895 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 1Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 2Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 3Olympic Champion Mary Lou Retton and ASCO Join Frosted Pink with a Twist to Empower Women Through Education and Advocacy 20891 4
The Blackstone Spinal Fixation System is a sophisticated fixation system that provides an innovative solution to spinal stabilization. It combines technical advances in strength and stability with a
...is a versatile, low profile, titanium implant comp...trumentation needed for implantation. Reduction in...g concept. Monosegmental and multisegmental applic... with over 8,000 implantations. Tested in accordan...
...em is a comprehensive and versatile hook, rod and ...nd degenerative cases. Conceived with a complete u...LA/VSP Spine System employs segmental fixation and...bilize the spine. In deformity cases, the ISOLA/VS...
Transcranial and peripheral vascular doppler system.
Medicine Products: